New App-Based study tracks Real-Life impact of melanoma combo therapy
NCT ID NCT07022457
First seen Apr 15, 2026 · Last updated May 14, 2026 · Updated 8 times
Summary
This study follows 50 adults in the UK with advanced melanoma who are starting a two-drug treatment (encorafenib and binimetinib). Instead of testing if the drugs work, researchers want to see how the treatment affects patients' daily lives and well-being over two years. Participants use a smartphone app to answer surveys about their quality of life, while doctors also provide medical records.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA, BRAF V600 MUTATION POSITIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrookes Hospital
Cambridge, CB20QQ, United Kingdom
-
Queen Elizabeth Hospital
Birmingham, B152GW, United Kingdom
-
Royal Marsden Hospital
London, SW36JJ, United Kingdom
-
Royal Preston Hospital
Preston, PR26GP, United Kingdom
-
Southampton General Hospital
Southampton, SO166YD, United Kingdom
-
Southend University Hospital
Westcliff-on-Sea, Essex, SS00RY, United Kingdom
-
University Hospital Coventry and Warwickshire
Coventry, CV22DX, United Kingdom
Conditions
Explore the condition pages connected to this study.